Physician profile
Sandra A Cho
NPI 1770522989
$6,984.79
in general payments reported to CMS, 2019-2025
33 companies · $2,351 in 2025
The $2,351 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $695 · 2021: $638 · 2022: $751 · 2023: $426 · 2024: $774 · 2025: $2,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,686 · Travel and Lodging: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,685.82 |
| Travel and Lodging | $864.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,049.96 | 2019-2025 | Collagenase Santyl, Versajet, Grafix |
| Organogenesis INC. | $1,028.37 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Stryker Corporation | $637.37 | 2019-2025 | Citrefix |
| Covidien LP | $550.00 | 2020 | |
| Integra Lifesciences Corporation | $474.89 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $354.75 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Mimedx Group, INC. | $293.93 | 2024-2025 | |
| Treace Medical Concepts, INC. | $191.89 | 2023-2025 | |
| Medtronic, INC. | $165.16 | 2024 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $125.26 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $122.22 | 2025 | |
| Janssen Pharmaceuticals, INC | $111.64 | 2019 | |
| Nevro Corp. | $96.23 | 2021 | |
| Orthofix Medical, INC. | $94.87 | 2022-2025 | Physio-Stim |
| Convatec INC. | $88.61 | 2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $87.22 | 2019-2022 | |
| Paragon 28, INC. | $68.12 | 2022-2023 | Ttc Nail |
| Terumo Medical Corporation | $66.64 | 2023 | Navicross |
| Takeda Pharmaceuticals U.S.A., INC. | $49.41 | 2019-2023 | Gattex |
| Vifor Pharma, INC. | $44.87 | 2020-2021 | |
| Dexcom, INC. | $35.28 | 2021-2023 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $30.02 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.52 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $28.51 | 2023 | Farxiga |
| Abbvie INC. | $27.06 | 2024 | |
| Sanofi-Aventis U.S. LLC | $19.98 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.78 | 2019 | |
| Kci USA, INC. | $19.12 | 2020 | |
| Mallinckrodt Hospital Products INC. | $18.33 | 2023 | Acthar |
| Opko Pharmaceuticals, LLC | $16.57 | 2019 | |
| Amgen INC. | $16.45 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.67 | 2019 | |
| Allergan, INC. | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.